Shalby peers

·Pharma & HealthChart ›

Companies like Shalbylatest year

ShalbySHALBY · FY26 · this company
Market cap₹1,205
P/E34.71×
Sales growth+11.7%
ROE3.7%
Gujarat Kidney And Super SpecialityGKSL · FY26
Open ›
Market cap₹1,403
P/E71.48×
Sales growth—
ROE6.1%
GPT HealthcareGPTHEALTH · FY26
Open ›
Market cap₹1,085
P/E25.67×
Sales growth+17.8%
ROE16.3%
Indraprastha Medical CorporationINDRAMEDCO · FY26
Open ›
Market cap₹2,750
P/E14.98×
Sales growth+8.4%
ROE27.5%

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SHALBY₹112.10

Shalby Limited

· Pharma & Health
₹ CrorePeersGKSLGPTHEALTHINDRAMEDCOARTEMISMEDLOTUSEYEDRAGARWQKMCSHILKOVAIMcap ₹1,205 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
SHALBY
FY26
GKSL
FY26
GPTHEALTH
FY26
INDRAMEDCO
FY26
Peer
Average
Valuation — at last close
P/E34.71×71.48×25.67×◆ 14.98×37.38× -7%
P/B◆ 1.20×5.56×4.03×3.71×4.43× -73%
EV/EBITDA11.64×50.67×12.51×◆ 9.32×24.17× -52%
Market Cap₹1,205 Cr₹1,403 Cr₹1,085 Cr₹2,750 Cr₹1,746 Cr -31%
Growth
Revenue CAGR 3Y◆ 12.35%——10.50%10.50% +18%
Revenue CAGR 5Y———19.30%19.30%
Net Income CAGR 3Y-19.97%——◆ 28.69%28.69% -170%
Revenue YoY (latest Q)11.74%—◆ 17.83%8.35%13.09% -10%
Net Income YoY (latest Q)36.70%—◆ 65.73%8.33%37.03% -1%
Profitability
EBITDA Margin12.51%◆ 32.85%17.81%18.00%22.89% -45%
Net Income Margin3.04%◆ 20.50%8.93%12.39%13.94% -78%
Return on Common Equity3.74%6.14%16.32%◆ 27.47%16.64% -78%
Return on Capital Employed5.79%8.24%16.42%◆ 29.88%18.18% -68%
Return on Assets1.96%5.65%9.95%◆ 19.93%11.84% -83%
Credit & Quality
Total Debt/Equity0.54×0.06×0.06×◆ 0.00×0.04× +1250%
Interest Coverage1.87×11.84×6.93×◆ 37.09×18.62× -90%
Scale — latest FY
Revenue / Total Income₹1,141 Cr₹82 Cr₹473 Cr₹1,483 Cr₹679 Cr +68%
Net Income₹34.7 Cr₹16.8 Cr₹42.2 Cr₹184 Cr₹80.9 Cr -57%
Total Assets₹1,839 Cr₹298 Cr₹465 Cr₹991 Cr₹585 Cr +215%
EPS₹3.23₹2.49₹5.15₹20.03₹9.22 -65%
Book Value per Share₹93.49₹32.03₹32.84₹80.76₹48.54 +93%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.